Targacept NNR Platform Lands In Billion-Dollar GSK Alliance July 30, 2007 By Jennifer Boggs Targacept Inc. got an impressive stock boost Friday, jumping 20 percent on an early stage deal with GlaxoSmithKline plc to develop drugs targeting neuronal nicotinic receptors for pain and other disorders. (BioWorld Today)Read More